VOYA Investment Management
CYCN icon

VOYA Investment Management’s Cyclerion Therapeutics CYCN Stock Holding History

VOYA Investment Management’s Portfolio CYCN Stock Details CYCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-602
Closed -$34K – 2834
2021
Q1 		$34K Hold
602
– – ﹤0.01% 2758
2020
Q4 		$37K Buy
+602
New +$41K ﹤0.01% 2674
2020
Q2 		– Sell
-656
Closed -$35K – 2532
2020
Q1 		$35K Sell
656
-183
-22% -$13.1K ﹤0.01% 2545
2019
Q4 		$46K Buy
+839
New +$78.3K ﹤0.01% 2649

Other funds holding CYCN

SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.77B AUM 72.29% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

VOYA Investment Management's CYCN Position: Q2 2021 in Review

VOYA Investment Management sold out of Cyclerion Therapeutics (CYCN) in Q2 2021, closing a stake of 602 shares — an estimated $34K sold.

VOYA Investment Management first reported a position in CYCN in Q4 2019 and held it in 4 quarters. The position peaked at $46K in Q4 2019. 67 funds tracked by Wall St. Rank hold CYCN as of Q2 2021.

  • VOYA Investment Management reported no remaining Cyclerion Therapeutics position as of Q2 2021 after selling out during the quarter.
  • VOYA Investment Management sold 602 Cyclerion Therapeutics shares in Q2 2021, an estimated $34K.
  • VOYA Investment Management first reported a position in Cyclerion Therapeutics in Q4 2019 and held it in 4 quarters.
  • VOYA Investment Management's Cyclerion Therapeutics position peaked at $46K in Q4 2019.
  • 67 funds tracked by Wall St. Rank held Cyclerion Therapeutics as of Q2 2021.

Based on VOYA Investment Management's 13F filing for Q2 2021, filed 16 Aug 2021.